| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Advanced Micro Devices, Inc. | NASDAQ | $108.25 billion | 89.87 USD | 1.26% |
| Advanced Nano Technologies Ltd | ASX | $250.37 m | 4.20 AUD | 2.44% |
| Advanced Oncotherapy PLC | LSE | £148.18 m | 44.40 GBX | 5.71% |
| Advanced Oxygen Technologies, Inc. | PINK | $411.62 k | 0.13 USD | -37.50% |
| Advanced Photonix, Inc. | NYSE | $4.52 billion | 45.60 USD | -0.98% |
| Advanced Proteome Therapeutics Corp. | TSX-V | $4.19 m | 0.15 CAD | -3.23% |
| Advanced Share Registry Limited | ASX | $33.52 m | 0.78 AUD | 4.00% |
| Advanced Vision Technology | FRA | 0.00 | 0.00% | |
| Advanced Voice Recognition Systems, Inc. | PINK | $3.92 m | 0.01 USD | 13.82% |
| AdvanSource Biomaterials Corp. | OTCQB | $706.56 k | 0.03 USD | 0.00% |
| Advant-e Corp. | PINK | $35.8 m | 6.00 USD | 4.35% |
| Advantage Lithium Corp. | TSX-V | $43.14 m | 0.27 CAD | -3.64% |
| Advantage Oil & Gas Ltd. | TSX | $395.04 m | 2.10 CAD | 0.00% |
| Advantaged CDN High Yield Bond Fund | TSX | $15.92 m | 7.31 CAD | -0.27% |
| Advantest | NYSE | 0.00 | 0.00% | |
| Advaxis | NASDAQ | $90.77 m | 0.83 USD | 19.51% |
| Advent Software, Inc. | NASDAQ | 0.00 | 0.00% | |
| Adventure Gold Inc | TSX-V | $0.00 | 0.00 CAD | 0.00% |
| ADVENTUS ZINC CORPORATION | TSX-V | $156 m | 1.19 CAD | -0.83% |
| Adveritas Ltd | ASX | $60.51 m | 0.17 AUD | -5.56% |
| Adverum Biotechnlogies Inc | NASDAQ | $1.32 billion | 13.52 USD | -2.87% |
| ADVFN | AIM | £7.22 m | 31.00 GBX | -1.59% |
| AdvisorShares ETF | NYSEMKT | $253.43 m | 22.06 USD | 0.59% |
| ADX Energy Limited | ASX | $17.62 m | 0.01 AUD | 12.50% |
| AECOM Technology | NYSE | $7.98 billion | 54.03 USD | -1.24% |
| Aecon Group | TSX | $1.05 billion | 17.59 CAD | -1.24% |
| Aeeris Ltd | ASX | $7.5 m | 0.13 AUD | 0.00% |
| AEGEAN Airlines | PINK | $426.36 m | 5.97 USD | -1.97% |
| Aegle Therapeutics Corp | Unlisted | 0.00 | 0.00% | |
| Aeglea Biotherapeutics | NASDAQ | $357.61 m | 7.49 USD | -2.85% |
| Aehr Test Systems | NASDAQ | $54.97 m | 2.34 USD | 0.43% |
| Aemetis Inc | NASDAQ | $85.3 m | 3.92 USD | -0.76% |
| Aeolus Pharmaceuticals, Inc. | PINK | $608.34 k | 0.00 USD | -20.00% |
| AEON Biopharma | Unlisted | 0.00 | 0.00% | |
| Aeon Metals Ltd | ASX | $98.25 m | 0.15 AUD | -3.33% |
| Aeorema Communications | AIM | £2.22 m | 24.00 GBX | 0.00% |
| AEP Industries | NASDAQ | 0.00 | 0.00% | |
| Aequus Pharmaceuticals Inc. | TSX-V | $16.79 m | 0.15 CAD | 7.14% |
| AER Lingus Group plc | LSE | 0.00 | 0.00% | |
| Aerie Pharmaceuticals | NASDAQ | $727.5 m | 15.54 USD | -2.63% |